CNV lesion

Related by string. * CNVs : CGH CNV . choroidal neovascularization CNV . CNV PREM . myopic CNV . number variation CNV . number variations CNVs . number variants CNVs . CNV / Lesions . Lesion . lesioned . lesions : metastatic lesions . pigmented lesions rejuvenate . target lesion revascularization . benign lesions . pigmented lesions . precursor lesions . pre cancerous lesions . Target Lesion Revascularization TLR * *

Related by context. Frequent words. (Click for all words.) 60 hematologic toxicity 57 parenchymal 57 extrapyramidal symptoms 57 carotid stenosis 56 laboratory abnormalities 55 plus MTX 55 sweat chloride 55 biochemical recurrence 55 chronicity 54 inflammatory lesions 54 sustained virological response 54 platelet reactivity 54 resorption 53 lymphadenectomy 53 neovascularization 53 cytogenetic response 53 disc degeneration 53 virologic response 53 dysplastic 53 cerebrovascular events 53 androgen deprivation 53 Alzheimer Disease Assessment 53 tumor shrinkage 53 symptomatology 53 tumor resection 53 recanalization 52 coagulopathy 52 amenorrhea 52 hippocampal volume 52 demyelination 52 kyphosis 52 cardiac dysfunction 51 prospectively defined 51 penetrance 51 Negative Syndrome 51 clinically meaningful improvement 51 cerebral ischemia 51 nonadherence 51 QTc prolongation 51 airflow obstruction 51 lymphopenia 51 ultrasonographic 51 Secondary endpoints included 51 MGUS 51 % CI #.#-#.# [007] 50 vascularity 50 HbA 1c 50 refractive error 50 neuropathological 50 posttreatment 50 posttraumatic 50 Consensus +#.# 50 virological failure 50 VUR 50 LVEF 50 CI -#.# 50 Kaplan Meier 50 tumor regression 50 ACR# response 50 heterotopic ossification 50 achieved statistical significance 50 neurologic symptoms 49 postop 49 atrophic 49 complete cytogenetic 49 onsets 49 hypocalcemia 49 hirsutism 49 nonfatal MI 49 estimated glomerular filtration 49 serum creatinine 49 hypercalcemia 49 glomerular filtration rate 49 collagen synthesis 49 fasting plasma glucose FPG 49 nephrectomy 49 ischaemia 49 ADAS cog 48 OGTT 48 pathophysiologic 48 HBV DNA 48 Secondary endpoints include 48 photodamage 48 hyperinsulinemia 48 p = .# [002] 48 neuropsychiatric symptoms 48 angulation 48 liver fibrosis 48 nonfatal stroke 48 telomere shortening 48 radiographically 48 univariate analysis 48 QTc 47 P = .# 47 nonresponders 47 Psoriasis Area 47 chemoradiotherapy 47 virologic failure 47 thromboembolism 47 microalbuminuria 47 Cmax

Back to home page